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ABSTRACT
Transgenic mice produced in this investigation contained the proximal promoter
elements. the genomic coding sequence and the 3' flanking region of bovine fJ-casein
and the 5' regulatory elements of bovine a-lactalbumin. Specifically, the gene
construct included the TATAA box, CAAT box and polyadenylation signal of
bovine fJ-casein in addition to the 5' regulatory elements of the bovine a-lactalbumin
gene. Four lines of transgenic mice were generated; they expressed bovine {3-casein
in their milk at concentrations of up to 10 mg mL -I. The milk from the transgenic
mice tended to be very viscous and a proportion of these mice stopped lactating
before the normal onset of involution. The time at which the abrupt involution
occurred was directly correlated to the amount of fJ-casein produced. Mice secreting
approximately 10 mg mL - I of fJ-casein in their milk stopped lactating approxi
mately 1-3 days after parturition while mice expressing 1-3 mg mL - I stopped
lactating around days 10-18. The high expressing mice appeared to lactate
normally on day 1 of lactation, but on day 3 the mammary gland morphology
revealed alveoli and ducts which were very distended and contained milk compo
nents. However, the viscous milk solution could not be removedfrom the gland at
this stage of lactation. There were also a number of alveoli that appeared to have
gone through the process of involution by day 3 of lactation.

INTRODUCTION
Bovine a-lactalbumin (a-la) regulatory regions have been shown to drive the
production of foreign proteins in the milk of transgenic mice in our laboratory as
*To whom correspondence should be addressed.

well as by others (Vilotte et al., 1989; Bleck & Bremel, 1991; Stinnakre et al.,
1991; Soulier et aI., 1992). It appears from these studies that most of the cis-acting
regulatory elements needed for maximal production of bovine a-la in the milk of
transgenic mice are present in the 5' flanking region of the gene. To confirm that
the bovine a-lactalbumin 5' flanking region was capable of driving high-level
expression of a foreign protein in the milk of transgenic animals and to generate a
gene construct that could be used to modify the characteristics and composition
of bovine milk, transgenic mice were produced containing a bovine f)-casein gene
construct that was controlled by the bovine a-lactalbumin 5' flanking region.
Bovine f)-casein was chosen for analysis due to its potential usefulness in the
modification of physical properties of the milk. The addition of f)-casein to cows'
milk can increase the speed of curd formation and the cheese curd firmness
(Richardson et al., 1992). Thus, an increase in the production of f)-casein will also
increase the cheese yield of the milk. It has been hypothesized that the production
of a modified f)-casein in cows' milk can change the functional characteristics of
the milk. The addition of a glycosylation site at amino acids 7 or 27 is postulated
to increase the emulsifying, foaming and gelling characteristics of f)-casein in the
milk (Richardson et al., 1992).
Transgenic animals containing a number of the casein genes have been generated,
though transgenes controlled by the casein 5' flanking regions have been expressed at
relatively low levels as compared to endogenous casein expression. The bovine aSl
casein, rabbit f)-casein and rat f)-casein 5' flanking regions all have been used to drive
the expression of transgenes in mice (Lee et al., 1988; Buehler et al., 1990; Meade et
aI., 1990). Transgenic animals containing these casein constructs showed expression
levels that were at most 1-10% of endogenous gene expression. From these data it
was hypothesized that the casein gene cluster (Gupta et aI., 1982; Threadgill &
Womack, 1990) is regulated by a major control element in addition to the basal
promoter elements found in the 5' flanking region of each of the casein genes (Lee et
al., 1989). However, recently it was shown that a caprine f)-casein gene construct
could be expressed at high levels in the milk of transgenic mice (Persuy et aI., 1992).
This gene construct was made up of 3·0 kb of 5' flanking, the entire genomic coding
region, and 6·0 kb of 3' flanking region from the caprine f)-casein gene. Milk from
animals expressing this transgene contained caprine f)-casein at concentrations up to
21 mg mL -1 which is twice the level in normal caprine milk. These results indicate
that the necessary cis-acting elements needed for maximal transgene expression may
be present in the caprine f)-casein gene construct.
Due to the discrepancies in the literature with respect to the ability of the casein
5' flanking regions to drive expression of genes in transgenic animals, we chose to
test the ability of the bovine a-lactalbumin 5' flanking region to drive the
production of bovine f)-casein in the milk of transgenic mice and examine the
characteristics of the mouse milk containing bovine f)-casein.
MATERIALS AND METHODS
Isolation of the a-lactalbumin!f)-casein gene construct for microinjection

An a-lactalbumin/f)-casein gene construct (pA-lac/f)-casein) was developed in our
laboratory that contained 2·0 kb of bovine a-lactalbumin 5' flanking region, the

entire 8·5 kb coding region of bovine fJ-casein and 150 bp of I)-casein 3' flanking
region (Fig. I). This hybrid construct was restriction digested out of the plasmid
clone (pA-lac 5'/Ii-casein) using the restriction enzyme HhaI. This digestion was
run on a 1·0% agarose gel and the band containing the 10·7 k b iX-Iactalbumin/ {i
casein construct was purified from the gel using the Qiaex gel extraction kit
(Qiagen. Chatsworth. CA). The resulting DNA was diluted in TE (IOmM Tris
HCI. pH = 7-4, I mM EDTA, pH = 8·0) for microinjection.
Production of transgenic mice
Mature C57B6 x DBA2J FI (B6D2) female mice were superovulated using
PMSG and hCG and mated with ICR or B6D2 males to yield fertilized embryos
for pronuclear microinjection. The embryos were microinjected with the DNA
construct and 40 normal-appearing two-cell embryos were then transferred to
each pseudopregnant recipient (University of Wisconsin-Madison Biotechnology
Center, Transgenic Mouse Facility). The resulting founder transgenic mice were
then continually backcrossed into the ICR outbred strain of mice. The transgenic
mice were maintained as heterozyogotes for the transgene throughout the analy
Sts.

Identification of transgenic mice
DNA was extracted from a portion of the mouse tail using the method descri
bed by Hogan el al. (1986). Polymerase chain reaction (PCR) was performed
using 10 III lOx PCR reaction buffer (500 mM KCI, 100 mM Tris-HCl
(pH=8·8). l5mM MgCI 2 • 1% Triton X-IOO), 200ttM each dNTP. I·OttM each
primer (Primer I: 5' CTCTTCCTGGATGTAAGGCTT 3'; Primer 2: 5'
CAAAGTAGAGGACAAGAAGT 3': these primers amplify the junction
+92 bp from the alpha
lactalbumin tsp
Bovine alpha
lactalbumin
5' flanking region

2.0kb

Bovine beta
casein genomic
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Bovine beta
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Fig. I. Map of the iX-LacS' /{i-casein gene construct. The construct contains 2·0 kb of
bovine iX-lactalbumin S' flanking region (Bleck & BremeL 1993) and 8·5 kb bovine {i-casein
genomic clone (Bonsing el al.• 1988). The two clones were joined at position +92 bp from
the ·iX-lactalbumin transcription start point and position -91 bp from the f3-casein tran
scription start point (tsp). The iX-lactalbumin portion of the construct contains the 5'
regulatory elements of the iX-lactalbumin gene and the putative 'milk box' (Vilotte Cl al..
1987) of the gene sequence. The {i-casein portion of the construct includes the Il-casein
C AAT box. TATA box, transcription start point. nine exons, polyadenylation signal and
150bp ofT flanking region.

between the IX-lactalbumin 5' flanking region and the f3-casein gene), 1 unit Tag
DNA polymerase and 1 Ilg genomic DNA. Volume was adjusted to 100 ilL with
double distilled sterile water and reaction was overlaid with light mineral oil.
Samples were subjected to 30 cycles (94°C 2 min, 50°C 1·5 min, 72 °C 1·5 min).
Products were run on a 1% agarose gel and stained with ethidium bromide.
Transgenic mice were characterized by the presence of a PCR band corre
sponding to the junction between the IX-lactalbumin 5' flanking region and 13
casein gene.
Mouse milking

Mice were separated from their litters for 4h and then anesthetized (0·01 mLg- 1
body weight intraperitoneal injection of 36% propylene glycol, 10·5% ethyl
alcohol, 41·5% sterile water, and 12% sodium pentobarbital, 50mgmL -I). After
being anesthetized the mice were injected intramuscularly with 0·3 international
units of oxytocin and milked using a small vacuum milking machine.
Gel electrophoresis and western blotting

The mouse milk was examined on a 14% SDS-PAGE reducing gel (Laemmli,
1970) or on a 12·5% Urea-PAGE gel (Swainsgood, 1975). Gels were either
stained with Coomassie Brilliant Blue R-250 or transferred onto Immobilon-P
membranes (Millipore, Bedford, MA) for western blotting. Immunoblotting was
carried out using a rabbit anti-bovine f3-casein antibody (Dr Bruce Larson,
Urbana, IL) and methods of Jimenez-Flores et al. (1989).
Histological analysis of mouse mammary glands

Mammary glands were removed from lactating mice and placed in 10% buffered
formalin. The glands were then paraffin embedded, sectioned, affixed to micro
scope slides and stained with hematoxylin and eosin.
RESULTS
Generation of transgenic mice

Four founder transgenic mice containing the bovine lX-lactalbumin/f3-casein gene
construct were produced. This gene construct contained approximately 2·0 kb of
bovine IX-lactalbumin 5' flanking region (-1983 bp to +92 pb from the IX-lactal
bumin transcription start point) attached to a bovine f3-casein genomic clone at
position -91 bp from the f3-casein transcription start point (Fig. 1). The IX-Lac5'/
f3-casein construct therefore contained the proximal promoter elements of 13
casein and the 5' regulatory elements of IX-lactalbumin. This 91 bp of f3-casein 5'
flanking region has been shown to be transcriptionally inactive in the mammary
epithelial eelliine CID-9 (Schmidhauser et al., 1992). Gene constructs containing
the 91 bp attached to the gene encoding chloramphenicol acetyltransferase (CAT)
were unable to drive CAT expression in these cells.
One female founder mouse died before a transgenic line could be established,

however milk samples were obtained from this mouse for analysis. Transgenic
lines have been produced from each of the three remaining founder mice and the
transgenes exhibit normal Mendelian inheritance (~50% of offspring from a
heterozygous transgenic mouse were transgenic).
Production of bovine f3-casein in the milk of transgenic mice
Milk from transgenic mice was analysed using SDS-PAGE and western blotting
of Urea-PAGE gels. One line of transgenic mice (UWo:/f341) containing the 0:
LacS'/f3-casein gene construct produced bovine f3-casein up to a concentration of
approximately to mg mL -1 in their milk (Fig. 2) and two other transgenic lines
secreted detectable levels of bovine f3-casein in their milk. The concentration of
bovine f3-casein in all three lines ranged from approximately 1mg mL -I to
IOmgmL -I in the high producing UWo:/f341 line (Table I). Concentrations of
protein were estimated using Coomassie Blue stained gels and the Collage 8
image analysis software (FOTODYNE, New Berlin, WI). This is a crude estimate
of bovine f3-casein concentration. A more precise measurement could not be
made due to the difficulty in getting a consistent milk sample from these animals
and also because of the large number of bovine f3-casein proteolytic and phos
phorylation variants observed. A western blot of the transgenic mouse milk
indicated a number of protein bands that reacted with the bovine f3-casein anti
body (Fig. 3). Since bovine f3-casein is a known substrate of plasmin, it is possible
that the smaller peptides are proteolytic products of the bovine f3-casein. Also,
bovine f3-casein is known to have a number of phosphorylation variants that may
show mobility differences in the urea-gel system.
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Fig. 2. Coomassie Blue stained SDS-PAGE gel of bovine fJ-casein containing transgenic
mouse milk. Lane I: control cow milk. Lanes 2 and 3: line UWIJ(-/14l mouse milk (two
dilutions). Lanes 4. 5 and 6: control mouse milk (samples from three different control
mice). Lanes 7 and 8: line UWIJ(//141 mouse milk (two dilutions). Arrows indicate location
of bovine {f-cascin.

TABLE 1
Levels of Bovine /3-Casein Expression in Mouse Milk and Observed Day of Premature
Mammary Involution
Transgenic line no.

Bovine /3-casein expression in
transgenic mouse milk (mg/mL)

Lactation length
(days)

1-3
8-12
Not detected
3-5

12-20
1-3
20
10--15

UWex//334
UWex//341
UWex//359
UWex//373

Characteristics of the transgenic mouse milk
The mouse milk containing bovine p-casein exhibited altered physical properties.
The milk was much more viscous and more difficult to remove from the gland
compared to control mouse milk. This difficulty in removing milk from the gland
and the small quantities of milk that could be obtained made it difficult to
produce consistent milk samples. For this reason, no accurate measurements of
fat, protein and water were possible for milk of the mice producing the high levels
of bovine p-casein. The mice producing low levels of the exogenous protein
("",1 mgmL -1) produced milk with fat, protein and water contents similar to
control mice. Mice expressing bovine p-casein also underwent a premature invo
lution of the mammary gland. Mice from the UW a! P41 line which expressed
bovine p-casein at concentrations of approximately 10 mg mL -I stopped lactating
on day 1-3 of lactation. Mice from the UWa!p34 line which secreted bovine p
casein at concentrations of approximately 1-3 mg mL -I stopped lactating on day
12-18 of lactation, with some finishing a 20 day lactation. However, pups from
UWa!p34 mice that lactated for a normal length of time appeared much smaller
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Fig. 3. Western blot of transgenic and control mouse milk. Samples were run on a 12·5%
Urea-PAGE gel. Lane I: partially purified bovine /3-casein (Sigma Chemical Co., St Louis,
MO). Lanes 2, 3 and 4: control mouse milk (samples from three different control mice).
Lanes 5 and 6: transgenic mouse milk (UWex//341). Arrows indicate the relative size of
endogeneously produced bovine /3-casein.

than control pups and some UWexl{334 mice continued to lactate past the typical
20 days if the pups were unable to obtain dry feed and water on their own at day
20 of lactation. The founder transgenic mouse, UWexl{373, also showed this same
early involution on approximately day 12 of lactation (two lactations: approx
imate average involution day), bovine {3-casein concentration in her milk was
approximately 3-5 mg mL -I. The premature involution was not observed in the
UW exl {359 line transgenic mice in which bovine {3-casein could not be detected.
The line UWexl{334 and line UWexl{341 mice that stopped lactating before the
normal end of lactation went through a normal second pregnancy, started to
lactate, but then again underwent the same premature involution. Pups from
these transgenic mice were foster nursed to maintain the transgenic line.
Mammary gland morphology of transgenic mice producing bovine {3-casein
On day I or day 3 after parturition, mammary glands from line UWexl{341 trans
genic mice and from control mice were removed, sectioned and stained to observe
morphology. Mammary glands from control mice taken on day I of lactation
showed normal, slightly distended alveolar structures and leftover milk compo
nents within the alveoli could be observed [Fig. 4(b)]. The mammary glands from
a day I lactating UWexl{341 mouse were much different as the alveolar structures
in these glands were more compact and not as distended as the control alveoli
[Fig. 4(a)]. Alveoli from the transgenic glands contained milk components that
appeared to be much denser than the components within the control alveoli.
Similar differences were observed in the glands on day 3 of lactation as the
alveolar structures from the day 3 control gland were more distended and fuller
of milk components than day I control alveoli [Fig. 5(b)]. However, the day 3
transgenic glands had alveolar structures that were smaller or the same size as
those observed in the day I transgenic glands [Fig. 5(a)]. Milk components within
these small alveoli again appeared very dense. Large ducts within the day 3
transgenic glands became very distended and filled with the dense milk compo
nents [Figs 5(a) and 6(a)] while the control large ducts were very irregular in
shape and the milk components showed the same appearance as in the control
alveoli [Fig. 6(b)]. The UWexl{341 mice were milked before the glands were
removed and no milk could be obtained, yet the glands appeared to be full of
milk components after sectioning. In addition, glands obtained from transgenic
mice on day 3 of lactation were approximately twice the size of control mice day 3
glands. Parts of the UWexl{341 transgenic glands showed involution of the
mammary alveoli already on day I of lactation [Fig. 7(a) and (b)]. The dense milk
components remained visible within baskets formed by myoepithelial cells around
the alveoli, but very few epithelial cells appeared to be present in this structure
and just a small amount of epithelial cell staining occurred in this region of the
gland.
DISCUSSION
Transgenic mice containing the ex-LacS' I{3-casein gene construct were capable of
producing a high concentration of bovine {3-casein in their milk. This construct
demonstrates the utility of combining genetic control regions of two milk protein

Fig. 4. Mouse mammary glands removed on day I of lactation. (a) Transgenic mammary
gland section (UWCl/P41), (b) Control mammary gland section. Arrows indicate the
alveolar lumen. Bar = 10 Jlm.

Fig. 5. Mouse mammary glands removed on day 3 of lactation. (a) Transgenic mammary
gland section (UWIX/P41). (b) Control mammary gland section. Arrows indicate the
alveolar lumen. Bar = 10 tIm.

Fig. 6. Large ducts from day 3 mouse mammary glands. (a) Transgenic mammary gland
section (UWIX/P41). (b) Control mammary gland section. Arrows indicate the ductal
lumen. Bar = 10 11m.

Fig. 7. Transgenic mouse (UWIX/P41) mammary gland removed on day I of lactation.
Transgenic mammary gland sections showing involution of the mammary alveoli on day I
of lactation. Arrows point to regions of apparent mammary involution. Bar = to pm.

genes to obtain high-level production of a transgene product. By linking
mammary-specific enhancer regions of various milk protein genes it may be
possible to obtain a very high production level of transgene products and yet
maintain the mammary-specificity of the transgene. Similar experiments have
been attempted using the rat p-casein promoter and the hormone response
elements of mouse mammary tumor virus (Greenburg et al., 1991). In those
experiments, the hormone response elements increased transgene expression, but
some of the mammary-specificity was lost. Enhancer elements from the milk
protein genes may be able to maintain the mammary specificity and in addition
increase expression of the gene construct in transgenic animals.
These data are the first report of a transgene product altering the physical prop
erties of milk. This appears to be different from the milchlos phenotype that has been
observed with the over-expression of whey acidic protein in the mammary gland of
transgenic mice (Burdon et al., 1991). In that study, the over-expression of whey
acidic protein led to underdeveloped mammary glands that were not capable of
synthesizing milk. Gland development in the bovine p-casein-expressing mice
seemed normal, but the milk itself was altered. The modified milk characteristics
then appeared to induce the premature involution of the mammary gland, and in
addition the expression of the transgene increased the viscosity of mouse milk. The
viscous milk was unable to be removed from the gland either by the pups or through
the use of vacuum aspiration after an oxytocin injection. These properties of the milk
and the mammary gland were very similar to results obtained when the a-lactal
bumin gene was "knocked out" of mice (Stinnakre et al., 1994). The build-up of milk
components within the mammary gland may be causing the premature involution of
the gland as it has been shown that the rate of mammary involution increases when
milk is not removed from the gland (Larson, 1985). These additional milk compo
nents within the gland increase the alveolar pressure which leads to a stoppage of
milk synthesis and a break up of the alveolar structure. Since the transgenic mice
were able to go through a normal second pregnancy and start another lactation it
appeared that no permanent damage was caused by the expression of bovine p
casein and the early involution of the gland. This indicated that the observed
phenomenon was similar to a normal involution of the mouse mammary gland.
The altered physical properties of milk observed in this study were not reported
to occur in transgenic mice expressing similar levels of caprine p-casein (Persuy et
al., 1992). Because the two p-caseins are more than 90% conserved at the amino
acid level, these two sets of data may indicate that functional differences or
processing variations of the p-casein molecule exist between the cow and the goat
and that these differences are associated with the unique behavior of bovine p
casein in mouse milk. A second hypothesis explaining the difference between the
bovine and the caprine data centers on the use of the bovine a-lactalbumin 5'
flanking region to control p-casein expression. Typically, a-lactalbumin serves as
a modulator of lactose production in the mammary gland. Lactose is the major
osmotic component in milk and its production is associated with the movement
of water into the lumen of the mammary gland. A reduction in the amount of a
lactalbumin produced may cause less lactose to be produced and less water
movement into the gland, resulting in a more viscous milk. The a-lactalbumin 5'
flanking region controlling the p-casein gene construct may be sequestering
necessary transcription factors needed for the production of normal mouse a
lactabumin and thus causing decreased production of mouse a-lactalbumin and

lactose. The possibility that a transcription factor may be rate limiting has been
suggested by a number of authors (Hirst et al., 1990; Wang & Miksicek, 1991;
Colgan & Manley, 1992). Studies are underway to examine the functional differ
ences between bovine fJ-casein-containing mouse milk and control mouse milk
with regards to apparent viscosity, composition and the potential bovine fJ-casein
variants observed in the mouse milk.

CONCLUSIONS
Transgenic mice producing a high level of bovine fJ-casein yielded abnormal milk
and stopped lactating before the normal onset of involution. These mice may
serve as a useful model to study the mechanisms of mammary involution as well
as the functional changes induced by the presence of bovine fJ-casein in mouse
milk. The bovine a-lactalbumin 5' flanking region proved to be a useful regula
tory region for driving bovine fJ-casein production in the milk of transgenic mice.
The a- Lac5'/fJ-casein gene construct can be used to make mutations in the fJ
casein gene and then to test the effects of these changes on the physical char
acteristics of modified bovine fJ-casein in the milk of transgenic animals.

ACKNOWLEDGEMENTS
We thank Dr Anthony Mackinlay for providing the bovine fJ-casein genomic
clone. The authors acknowledge the assistance of Dr Jan Lohse in generating the
transgenic mice. The technical assistance of Ed Metcalf and Jim Wentzel is also
appreciated. G. T. Bleck was supported by a USDA Biotechnology Fellowship.
This project was supported by the Wisconsin Milk Marketing Board.
REFERENCES
Bleck, G.T. & Bremel, R.D. (1991). Expression of bovine :x-lactalbumin in the milk of
transgenic mice containing a 6-4 kilobase genomic clone of bovine :x-lactalbumin. J.
Cellular Biochem., Supp. 15A, 198.
Bleck, G.T. & Bremel, R.D. (1993). Sequence and single-base polymorphisms of the bovine
:x-lactalbumin Y-flanking region. Gene, 126,213-18.
Bonsing, J., Ring, J.M., Stewart, A.F. & Mackinlay, A.G. (1988). Complete nucleotide
sequence of the bovine beta-casein gene. Aust. J. Bioi. Sci., 41, 527~37.
Buehler, T.A., Bruyere, T., Went, D.F., Stranzinger, G. & Buerki, K. (1990). Rabbit {j
casein promoter directs secretion of human interleukin-2 into the milk of transgenic
rabbits. Bio/technology, 8, 140--3.
Burdon, T., Wall, R.J., Shamay, A., Smith, G.H. & Henninghausen, L. (1991). Over
expression of an endogenous milk protein gene in ransgenic mice is associated with
impaired mammary alveolar development and a milchos phenotype. Mech. Dev., 36.
67~74.

Colgan, J. & Manley, J.L. (1992). TflID can be rate limiting in vivo for TATA-containing.
but not TATA-Iacking RNA polymerase II promoters. Genes Dev., 6, 304-315.
Gupta, P., Rosen, J.M., D'Eustachio, P. & Ruddle, F.H. (1982). Localization of the casein
gene family to a single mouse chromosome. J. Cell. BioI., 93, 199--204.

Greenburg, N.M., Reding, T.V., Duffy, T. & Rosen, J.M. (1991). A heterologous hormone
response element enhances expression of rat fJ-casein promoter-driven chloramphenicol
acetyltransferase fusion genes in the mammary gland of transgenic mice. Mol. Endocr.,
5, 1504-12.
Hirst, M.A., Northrop, J.P., Danielsen, M. & Ringold, G.M. (1990). High level expression
of wild type and variant mouse glucocorticoid receptors in chinese hamster ovary cells.
Mol. Endocr., 4, 162-70.
Hogan, B., Constantini, F. & Lacy, E. (1986). Manipulating the Mouse Embryo: A
Laboratory Manual, Cold Spring Harbor Laboratory, New York, NY, pp. 175-6.
Jimenez-Flores, R., Richardson, T. & Bisson, L. (1989). Expression of bovine fJ-casein in
Saccaromyces cerevisiae and characterization of the protein produced in vivo. J. Agric.
Food Chem., 38, 1134-1141.
Laemmli, U.K. (1970). Cleavage of structural proteins during the assembly of the head of
bacteriophage T4. Nature, 227, 680-5.
Larson, B.L. (1985). Lactation, The Iowa State Press, Ames, lA, pp. 24-5.
Lee, K.-F., DeMayo, J., Atiee, S.H. & Rosen, J.M. (1988). Tissue-specific expression of the
rat fJ-casein gene in transgenic mice. Nucl. Acids Res., 16, 1027--41.
Lee, K.-F., Atiee, S.H., Henning, S.J. & Rosen, J.M. (1989). Relative contribution of
promoter and intragenic sequences in the homonal regulation of rat fJ-casein trans
genes. Mol. Endocr., 3, 447-53.
Meade, H., Gates, L., Lacy, E. & Lonberg, N. (1990). Bovine IXsl-casein gene protein
chemistry sequences direct high level expression of active human urokinase in mouse
milk. Bio/technology, 8, 443-6.
Persuy, M-A., Stinnakre, M.-G., Printz, c., Mahe, M.-F. & Mercier, J-c. (1992). High
expression of the caprine fJ-casein gene in transgenic mice. Eur. J. Biochem., 205, 887
93
Richardson, T., Oh, S., Jimenez-Flores, R., Kumosinski, T.P., Brown, E.M. & Farrell, H.
(1982). Advanced Dairy Chemistry~ 1: Proteins, ed. P.F. Fox, Elsevier Applied Science,
London, pp. 545~77.
Schmidhauser, c., Casperson, G.F., Myers, C.A., Bolten, S. & Bissell, M.J. (1992). A
novel transcriptional enhancer is involved in the prolactin and ECM-dependent regu
lation of fJ-casein gene expression. Mol. Bioi. Cell, 3, 699-709.
Soulier, S., Vilotte, J.L., Stinnakre, M.G. & Mercier, J.-c. (1992). Expression analysis of
ruminant IX-lactalbumin in transgenic mice: Developmental regulation and general
location of important cis-regulatory elements. FEBS Lett., 297, 13-18.
Stinnakre, M.G., Vilotte, J.L., Soulier, S., L'Haridon, R., Chalier, M., Gaye, P. & Mercier,
J.-c. (1991). The bovine IX-lactalbumin promoter directs expression of ovine trophoblast
interferon in the mammary gland of transgenic mice. FEBS Lett., 284, 19-22.
Stinnakre, M.G., Vilotte, J.L., Soulier, S. & Mercier, J.-c. (1994). Creation and pheno
typic analysis of IX-lactalbumin-deficient mice. Proc. Natn. A cad. Sci. 91, 6544-8.
Swaisgood, H.E. (1975). Methods of Gel Electrophoresis of Milk Proteins, American Dairy
Science Association, Champaign, IL.
Threadgill, D.W. & Womack, J.E. (1990). Genomic analysis of the major bovine milk
protein genes. Nucl. Acid Res., 18, 6935--42.
Vilotte, J., Soulier, S., Mercier, J.-c., Gaye, P., Hue-Delahaie, D. & Furet, J.-P. (1987).
Complete nucleotide sequence of bovine alpha-lactalbumin gene: comparison with its
rat counterpart. Biochimie, 69, 609-20.
Vilotte, J.L., Soulier, S., Stinnakre, M.-G., Massoud, M. & Mercier, J.-c. (1989). Efficient
tissue-specific expression of bovine IX-lactalbumin in transgenic mice. Eur. J. Biochem.,
186,43-8.
Wang, Y. & Miksicek, R.J. (1991). Identification of a dominant negative form of the
human estrogen receptor. Mol. Endocr., 5, 1707-15.

